Mark A. Ator
8Patents
4h-index
25Co-inventors
57Inventor score
Filing activity: May 19, 1995 → Jul 31, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6121266A | Pyridazines as interleukin-1.beta. converting enzyme inhibitors | Chemistry; Metallurgy | 9 | Expired |
| US5872207A | N-terminal-marked peptides immobilized on glass beads and method of preparation and method of use thereof | Emerging Cross-Sectional Technologies | 7 | Expired |
| US7122679B2 | Multicyclic compounds and the use thereof | Chemistry; Metallurgy | 6 | Expired |
| US5985838A | Peptide analogs as irreversible interleukin-1.beta. protease inhibitors | Chemistry; Metallurgy | 5 | Expired |
| US6576614B1 | Peptide analogs as irreversible interleukin-1&bgr; protease inhibitors | Chemistry; Metallurgy | 2 | Expired |
| US10028956B2 | Methods of treating various cancers using an AXL/cMET inhibitor in combination with other agents | Human Necessities | 0 | Active |
| US6995261B2 | 4-pyridazinecarboxamides and esters as interleukin-1β converting enzyme inhibitors | Chemistry; Metallurgy | 0 | Expired |
| US6624166B1 | Pyridazines as interleukin-1&bgr; converting enzyme inhibitors | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.